Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myeloid, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Weight Loss 1Waldenstrom Macroglobulinemia 1Thrombocytopenia 1Splenomegaly 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Sarcoma, Myeloid 1Recurrence 1Preleukemia 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lymphocytosis 1Lymphadenopathy 1Lung Neoplasms 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1

Interventions

AP 1903 reagent 3ON 01910 2Biopsy 2thymoglobulin 1fludarabine phosphate 1fludarabine 1epacadostat 1Specimen Handling 1Sertraline 1Peripheral Blood Stem Cell Transplantation 1Metformin 1IDO-1 inhibitor LY3381916 1Granulocyte Colony-Stimulating Factor 1Genetic Counseling 1Filgrastim 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1Bone Marrow Transplantation 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cytopenia × Metformin × Other hematologic neoplasm × Clear all
NCT04741945 2024-11-22

Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS

Rigshospitalet, Denmark

Phase 2 Recruiting
40 enrolled
Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Refractory, with Excess of Blasts, Preleukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡